Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celso Arango

Showing results (381-390 of 504) with videos related to

Pageof 51
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 15, 2025
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiquesBenjamin W Bond, Bea Duric, Edoardo Spinazzola, et al.
Schizophrenia Bulletin|May 4, 2026
Childhood Adversities and Psychosis Across Populations: Insights From the 6-Country EU-GEI StudyCraig Morgan, Charlotte Gayer-Anderson, Lucia Sideli, et al.
Neuroimage. Clinical|July 24, 2020
Specific cortical and subcortical alterations for reactive and proactive aggression in children and adolescents with disruptive behaviorJilly Naaijen, Leandra M Mulder, Shahrzad Ilbegi, et al.
Neuroscience and Biobehavioral Reviews|March 31, 2023
The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indicationsSamuele Cortese, Katherine McGinn, Mikkel Højlund, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 9, 2020
Universal and selective interventions to promote good mental health in young people: Systematic review and meta-analysisGonzalo Salazar de Pablo, Andrea De Micheli, Dorien H Nieman, et al.
Psychological Medicine|December 16, 2024
Triangulating the associations of different types of childhood adversity and first-episode psychosis with cortical thickness across brain regionsNatalia E Fares-Otero, Norma Verdolini, Helena Melero, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 1, 2025
Schizophrenia treatment preferences of psychiatrists versus guidelines: A European perspectiveMartina Rojnic Kuzman, Merete Nordentoft, Andrea Raballo, et al.
Psychological Medicine|April 22, 2022
Age-related brain deviations and aggressionNathalie E Holz, Dorothea L Floris, Alberto Llera, et al.
Biological Psychiatry|March 23, 2024
Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental DisordersJavier González-Peñas, Clara Alloza, Rachel Brouwer, et al.
The Lancet. Psychiatry|September 26, 2015
Mental health research priorities for EuropeTil Wykes, Josep Maria Haro, Stefano R Belli, et al.
Pageof 51

Showing results (381-390 of 504) with videos related to

Sort By:
Pageof 51
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 15, 2025
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiquesBenjamin W Bond, Bea Duric, Edoardo Spinazzola, et al.
Schizophrenia Bulletin|May 4, 2026
Childhood Adversities and Psychosis Across Populations: Insights From the 6-Country EU-GEI StudyCraig Morgan, Charlotte Gayer-Anderson, Lucia Sideli, et al.
Neuroimage. Clinical|July 24, 2020
Specific cortical and subcortical alterations for reactive and proactive aggression in children and adolescents with disruptive behaviorJilly Naaijen, Leandra M Mulder, Shahrzad Ilbegi, et al.
Neuroscience and Biobehavioral Reviews|March 31, 2023
The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indicationsSamuele Cortese, Katherine McGinn, Mikkel Højlund, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 9, 2020
Universal and selective interventions to promote good mental health in young people: Systematic review and meta-analysisGonzalo Salazar de Pablo, Andrea De Micheli, Dorien H Nieman, et al.
Psychological Medicine|December 16, 2024
Triangulating the associations of different types of childhood adversity and first-episode psychosis with cortical thickness across brain regionsNatalia E Fares-Otero, Norma Verdolini, Helena Melero, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 1, 2025
Schizophrenia treatment preferences of psychiatrists versus guidelines: A European perspectiveMartina Rojnic Kuzman, Merete Nordentoft, Andrea Raballo, et al.
Psychological Medicine|April 22, 2022
Age-related brain deviations and aggressionNathalie E Holz, Dorothea L Floris, Alberto Llera, et al.
Biological Psychiatry|March 23, 2024
Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental DisordersJavier González-Peñas, Clara Alloza, Rachel Brouwer, et al.
The Lancet. Psychiatry|September 26, 2015
Mental health research priorities for EuropeTil Wykes, Josep Maria Haro, Stefano R Belli, et al.
Pageof 51